This review provides a comprehensive summary of recent advances in the α-syn/TLRs/NF-κB/NLRP3 inflammasome axis of microglia as a useful advent for PD management by inhibiting microglial activation. This evidence concerns the gene NLRP3 and Parkinson disease.